IHH Healthcare Growth Likely Driven by Malaysia, India Markets -- Market Talk

Dow Jones09:06

0106 GMT - IHH Healthcare could see a decent growth trajectory into 2026, driven mainly by Malaysia and India markets, TA Securities analyst Tan Kong Jin says in a note. In Malaysia, revenue is forecast to grow 12.3%, supported by higher day care volumes, medical tourism and bed expansion, while margins are set to improve on cost discipline, he says. India operations could recover as integration between Fortis and Gleneagles units improves efficiency and margins, he reckons. Singapore market should stabilize by 2H, supported by the ramp-up of ambulatory care centers, medical tourism growth, and the expansion of Mount Elizabeth hospital, he adds. TA Securities maintains a buy rating on IHH and keeps the target price at 10.30 ringgit. Shares are unchanged at 8.85 ringgit.(yingxian.wong@wsj.com)

 

(END) Dow Jones Newswires

April 23, 2026 21:06 ET (01:06 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment